Skip to search formSkip to main contentSkip to account menu

visilizumab

Known as: Anti CD3, Anti-CD3 Antibody 
A humanized, non-Fc receptor (FcR)-binding IgG2 monoclonal antibody (MoAb) directed against CD3 with potential immunosuppressive activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2007
Highly Cited
2007
Despite the recent improvement in the treatment of ovarian cancer, this disease is still leading cause of cancer death in women… 
2005
2005
After stimulation with anti‐CD3 antibody in vitro, CD57+ T cells showed a greater susceptibility to apoptosis than CD57–αβT cell… 
2002
2002
BACKGROUND Clinical and experimental studies have shown that an important deleterious consequence of excessive alcohol… 
2000
2000
Owing to the contrasting observations in the field of interleukin(IL)‐2 receptor research, the expression of IL‐2 receptor chains… 
1999
1999
Interleukin-12 (IL-12) is a heterodimeric cytokine that enhances the cytolytic activity, proliferation, and interferon-gamma (IFN… 
1993
1993
A thymic epithelial cell line (TEC1-4) established from newborn mouse thymus produced a cofactor to promote proliferation of… 
1989
1989
Ligand binding and cross-linking of TCR/CD3 complex leads to T cell stimulation in immunologic responses. As a prelude to… 
Highly Cited
1989
Highly Cited
1989
We analyzed the mechanism by which accessory cells support the induction of the proliferation of human peripheral blood T cells… 
1989
1989
This paper examines the possibility of a functional linkage between class I MHC molecules and the T-cell receptor complex for…